Invion Limited Stock Performance
| IVIXF Stock | USD 0.04 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Invion are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Invion Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Invion is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1 M | |
| Total Cashflows From Investing Activities | -7.2 M |
Invion |
Invion Relative Risk vs. Return Landscape
If you would invest 3.69 in Invion Limited on November 30, 2025 and sell it today you would earn a total of 0.00 from holding Invion Limited or generate 0.0% return on investment over 90 days. Invion Limited is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Invion, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Invion Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Invion for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Invion Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Invion Limited generated a negative expected return over the last 90 days | |
| Invion Limited has some characteristics of a very speculative penny stock | |
| Invion Limited has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.29 M. Net Loss for the year was (2.24 M) with profit before overhead, payroll, taxes, and interest of 969.12 K. | |
| Invion Limited has accumulated about 8.47 M in cash with (1.11 M) of positive cash flow from operations. | |
| Roughly 47.0% of the company shares are held by company insiders |
Invion Fundamentals Growth
Invion Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Invion, and Invion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Invion Pink Sheet performance.
| Return On Equity | -0.18 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (0.68) % | |||
| Operating Margin | (0.68) % | |||
| Current Valuation | 33.28 M | |||
| Shares Outstanding | 6.42 B | |||
| Price To Book | 4.08 X | |||
| Price To Sales | 16.38 X | |||
| Revenue | 3.29 M | |||
| EBITDA | (1.9 M) | |||
| Cash And Equivalents | 8.47 M | |||
| Debt To Equity | 0.20 % | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (1.11 M) | |||
| Total Asset | 20.04 M | |||
About Invion Performance
By analyzing Invion's fundamental ratios, stakeholders can gain valuable insights into Invion's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Invion has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Invion has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company was incorporated in 2000 and is headquartered in Melbourne, Australia. Invion operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Invion Limited performance evaluation
Checking the ongoing alerts about Invion for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Invion Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Invion Limited generated a negative expected return over the last 90 days | |
| Invion Limited has some characteristics of a very speculative penny stock | |
| Invion Limited has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.29 M. Net Loss for the year was (2.24 M) with profit before overhead, payroll, taxes, and interest of 969.12 K. | |
| Invion Limited has accumulated about 8.47 M in cash with (1.11 M) of positive cash flow from operations. | |
| Roughly 47.0% of the company shares are held by company insiders |
- Analyzing Invion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Invion's stock is overvalued or undervalued compared to its peers.
- Examining Invion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Invion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Invion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Invion's pink sheet. These opinions can provide insight into Invion's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Invion Pink Sheet analysis
When running Invion's price analysis, check to measure Invion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invion is operating at the current time. Most of Invion's value examination focuses on studying past and present price action to predict the probability of Invion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invion's price. Additionally, you may evaluate how the addition of Invion to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |